Professional Documents
Culture Documents
SN3209 Health and Ageing: Week 12 Promoting Wellness in Psychosocial Function: Cognitive Health
SN3209 Health and Ageing: Week 12 Promoting Wellness in Psychosocial Function: Cognitive Health
Week 12
Promoting wellness in psychosocial function:
Cognitive Health
Yu et al (2012)
Estimated and projected numbers of people living in community with dementia in Hong Kong, by age group and sex, 2009 and 2039.
Types of Dementia
Different types of dementia
Lacunar infarct in
subcortical area
Mixed dementia
• It means co-existing of
AD and VaD pathologies
• However, more
evidence shows that
there is a strong
overlap between
pathology of AD/VaD
• Evidence tends to
advocate that dementia
is caused by an
interaction between AD
and VaD pathologies.
Diagnosis of dementia
Lifestyle 2
• Cognitive training • Social engagement, e.g
• Physical activity • Doing volunteer work,
joining a club, or going
• Reduce risk of CI/
to church
improve cognitive fx
• Good even with mild PA
such as walking
• Should be regular, more
vigorous
Modifiable risk factors
• Behavioral symptoms
• Usually identified on the basis of observation of the
patient, including physical aggression,
• screaming, restlessness, agitation, wandering, culturally inappropriate
behaviors, sexual
• disinhibition, hoarding, cursing and shadowing.
• Psychological symptoms
• Usually and mainly assessed on the basis of interviews with
patients and relatives; these symptoms include
• anxiety, depressive mood, hallucinations and delusions.
BPSD
Drugs Non-drug
1) Cholinesterase inhibitors 1) Cognitive stimulation
2) NMDA receptor 2) Multi-component
antagonists interventions for the PWD
3) Psychotropic drugs 3) Behavioral interventions
• Target on outcome of:
-Cognitive function
4) Professional CG training
-Neuropsychiatric symptoms • Target on outcome of:
-Cognitive function
-Behavior
-Mood -Neuropsychiatric symptoms
-Quality of life -Quality of life
Santaguida p, et al, 2004 -Caregiver stress
For more info about non-drug treatment, please read Olanzaren et al, 2010
Reference
• Fratiglioni, L, Launer LJP, Anersen KM., et al. (2000). Incidence of dementia and major subtypes in Europe: a collaborative study of
population-based cohorts. Neurology, 54, p10-15.
• Ligthart, S. A., Charante, E. P. M., Cool, W. A. V., & Richard, E. (2010). Treatment of cardiovascular risk factors to prevent cognitive decline
and dementia: a systematic review. Vascular Health and Risk Management, 6, p 775-785.
• Sandtaguida, P. Raina, P., Booker, L., et al. (2004) Pharmacological treatment of dementia. Rockville (MD): Agency for Healthcare Rsearch
and Quality (US). (Evidence Reports/Technology Assessments, No. 97.)
• Olazaren, J., et al. (2010). Non-pharmacological therapies in Alzheimer’s disease: a systematic review of efficacy. Dementia and Geriatric
Disorder, 30, p. 161-178.
• 衞生署長者健康服務. (2007). 老年癡呆症常見疑問. 天地圖書: 香港
• Mobile Cognitive Assessment Clinic, Psychogeriatic department, Castle Peak Hospital http://www3.ha.org.hk/cph/mcac/e-knowledge.htm
• Reisberg B, Ferris SH, Leon MJ, et al. The global deterioration scale for assessment of primary degenerative dementia. American Journal of
Psychiatry 1982;139:1136-1139.
• Acevedo, A., Loewenstein, D.A. (2007). Nonpharmacological cognitive interventions in aging and dementia. Journal of Geriatric Psychiatry
Neurology, 20(4), p. 239-249.
• Bayer, A.J., Bullock, R., Jones, R.W. (2005). Evaluation of the safety and immunogenicity of synthetic amyloid beta 42 (AN1792) in patients
with AD. Neurology, 64, 94-101.
• Morris J.C. The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology,1993; 43:2412-2414.
• Fortinsky, R. H. (2001). Health care triads and dementia care: integrative framework and future directions. Aging & Mental Health, 5
(Supp 1), S35-48.
• Timothy, D. (2003). Person-centred dementia care: a vision to be refined. The Canadian Alzheimer Disease Review,
Reference
• Chenowth, L., King, M. T., Jeon, Y. H., Brodaty, H., Stein-Parbury, J., Norman, R., Haas, M., & Luscombe, G. (2009). Caring for aged
demenia care resident study (CADRES) of person-centred care, dementia-care mapping, and usual care in dementia: a cluster-
randomized trial. Lance Neurology, 8, p 317-325.
• International Pscyhogeriatric Association. (2002). Behavioral and psychological symptoms of dementia (BPSD) education pack.
Downloaded at http://www.ipa-online.org/ipaonlinev3/ipaprograms/bpsdarchives/bpsdrev/1BPSDfinal.pdf on Aug 24, 2011.
• Robinson, L., Dickinson, C., Rousseau, N., Beyer, F., Clark, A., Hughes, J., Howel, D., & Exley, C. (2011). A systematic review of the
effectiveness of advance care planning interventions for people with cognitive impairment and dementia. Age and Ageing, 0, 1-7.
doi:10.1093/ageing/afr148.
• Nobili, A., Piana, I., Balossi, L., Pasina, L., Matucci, M., … & Tettamanti, M. (2008). Alzheimer special care units compared with
traditional nursing home for dementia care: Are there differences at admission and in clinical outcomes? Alzheimer Dis Assoc
Disord, 22(4), 352-361.
• Rosvik, J., Brooker, D., Mjorud, M., & Kirkevold, O. (2013). What is person-centred care in dementia? Clinical reviews into practice:
the development of the VIPS practice model. Reviews in Clinical Gerontology, 23, 155-163.
• Rosvik, J., Kirkevoid, C., Engedal, K., Broker, D., Kirkevold O. (2011). A model for using the VIPS framework for person-centred care
for persons with dementia in nursing homes: a qualitative evaluative study. International Journal of Older People Nursing, 6(3), 227-
236.